Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...

SKAN AG / Key word (s): Preliminary Results SKAN announces preliminary key figures for the 2024 financial year 22-Jan-2025 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The ...

to file treatment protocols, which would allow physicians to use their drugs ahead of approval. The situation could also boost sales of Allschwil-based Actelion's Zavesca (miglustat).

Based in Allschwil, Alentis specialises in antibody-drug conjugates (ADCs) and antibodies targeting CLDN1 for oncology and multi-organ fibrosis treatments. The company's lead ADC candidate ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Talquetamab is a T-cell–redirecting bispecific antibody targeting G protein–coupled receptor class C group 5 member D (GPRC5D). 13-15 In the MonumenTAL-1 study, more than 71% of the patients ...

With 37 new spin-offs, ETH Zurich continues its long-term upward trend in the launch of new companies from its research.

Black individuals frequently present with resistant hypertension and disproportionately increased cardiovascular risk. We investigated the blood pressure (BP)-lowering effect of the dual endothelin ...

Drawing on a fascinating enabling technology of photo alignment, Rolic continually develops novel applications for use in manufacturing of LCDs, OLEDs, OVPs and innovative security elements.

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Spatial repellents have ...